Enzymes
The following enzymes were used: (a) Vibrio cholerae neuraminidase (VCN). This was obtained (BehringwerkeBatch 966c) and used in 0-05 M sodium acetate-acetic acid buffered saline at pH 5 5, containing 1 mg./ml. calcium chloride. Each ml. of this preparation contained 500 " units " of enzyme activity. One unit of activity is defined as the amount of enzyme which will release 1 fig. of N-acetyl neuraminic acid (NANA) from an al glycoprotein in 15 minutes at 370 C. It is a purified preparation containing no other glycolytic or proteolytic activity. It is also free of NANAaldolase.
(b) Clostridium perfringens neuraminidase (CPN) (Sigma type VI) is a chromatotographically purified enzyme preparation. It was dissolved in acetate-buffered saline to a concentration equivalent to 500 units/ml. (as defined above).
(c) Inactivated influenza virus (Flugen-Burroughs Wellcome) was used as a source of influenza neuraminidase (FLU N). This preparation contained substrains of A2 and B/England viruses. Each ml. contained 15,000 HA units (haemagglutination).
(d) Trypsin (Difco 1: 250) was made up in HBSS to 0-2 per cent at pH 7 2.
(e) Ribonuclease (RNAse). The preparation was a four times recrystallized extract of bovine pancreas (B.D.H.) and was used as a 1 mg. per ml. solution in HBSS at pH 7-2.
(f) Hyaluronidase. Bovine hyaluronidase 1500 units/ml. (Fisons) was made up in HBSS at pH 7-2.
Enzyme treatment of tumour cells.
Washed cells were suspended in the enzyme preparations at 370 C. with gentle mixing in a roller-tube incubator. After, and between, series of treatments the cells were washed 6 times in at least 50 volumes of HBSS. Twenty million tumour cells were incubated in each ml. of enzyme solution.
Viability
After all treatments the cells were tested for their ability to exclude trypan blue. Dye exclusion " viabilities " are expressed as the number of dye-excluding cells as a percentage of the total cell count. Control cells were incubated in the appropriate buffers (i.e. acetate buffered saline or HBSS) and their dye-exclusion " viabilities " also measured.
Electrophoretic mobility of tumour cells
Electrophoretic mobilities were measured in a cylindrical microelectrophoresis apparatus (Bangham et al., 1958) . The cells were suspended in HBSS at pH 7-2 and their mobilities measured in both directions. The results are the mean of 20 observations on each preparation and are expressed in /t/sec./v/cm. Test for imrnunogenicity
Immunogenicity is a relative term especially when applied to tumours. Therefore an entirely empirical system was employed in the present experiments. Each mouse received 4 X 106 cells, either treated or control, and was observed for tumour development for 30 days. The mice which survived 30 days after this inoculation and were clinically tumour-free were then rechallenged by the intraperitoneal injection of 5 X 104 untreated cells (approximately 5000 times the LD50 for this tumour). These mice were then observed for a further 60 days. All mice which survived this period were considered to be " immune " and the cell preparation which induced such a state was termed " immunogenic ". No mouse which was immune in this system has subsequently developed tumour, either peritoneal or at the injection site (up to 300 days later).
RESULTS
Vibrio cholerae neuraminidase (VCN) ( Table I) Incubation in VCN for 30 minutes caused a marked fall in the electrophoretic mobility of the Landschuitz tumour cells (Table IV) . Their dye-exclusion "viability " was not significantly different from the control cells incubated in buffer alone. However this VCN treatment greatly enhanced the immunogenicity of the cells, inducing a powerful anti-tumour immunity in all the injected mice.
Incubation in VCN at 40 C. for 30 minutes had no effect on the in vivo development of the tumour cells indicating that the enzyme activity is temperature dependent. When cells, treated with VCN at 370 C. for 30 minutes and washed thoroughly, were mixed with an equal number of untreated cells the resulting cell suspension was still highly immunogenic, illustrating that only a proportion of the inoculated cells need to be subjected to neuraminidase treatment to inhibit subsequent tumour development.
Other types of neuraminidase (Table II) When tumour cells were incubated with an inactivated influenza virus preparation, a potent source of influenza virus neuraminidase (FLU N), for 30 minutes at 370 C. there was no effect on the subsequent growth of the cells in vivo. Even after incubation for 180 
Trypsin
(a) Mucin Release. -Weiss (1958) has described the release of a web of mucinous material from the surface of ascites tumour cells in vitro by incubation with trypsin. Treatment of Landschutz ascites tumour cells in 0-2 per cent trypsin for 60 minutes at 370 C. produced a similar fine clot of such material in the suspension. However, when the cells had been pretreated with VCN for 30 minutes the amount of mucinous material released by trypsin was greatly increased. Difficulty was experienced in obtaining adequate numbers of freely suspended cells from such preparations as they tended to adhere to, and became involved in, the massive clot. This was overcome by increasing the number of cells employed (100 X 106) and the volume of trypsin (5 ml.) and gently agitating the preparation to release enough cells for subsequent experiments.
(b) Immunogenicity (Table III) .-When Landschutz tumour cells were incubated in 0-2 per cent trypsin at 370 C. for 60 minutes no effect on their subsequent growth in mice was detectable, i.e. trypsin alone had no apparent effect on their immunogenicity. However, subsequent treatment of these trypsinized cells with VCN for 30 minutes greatly increased their immunogenicity in vivo. VCN treated cells, however, lost their immunizing ability, after incubation in trypsin, suggesting that the antigenic sites exposed by VON treatment are hydrolysed by the trypsin. VCN pretreated cells, trypsinized and subsequently incubated in VCN for a further 30 minutes remained non-immunogenic and produced tumour in all the recipient mice, implying that all available antigenic sites were exposed by the preliminary VCN treatment and then degraded by trypsin. Similarly, trypsinized cells rendered immunogenic by VCN treatment, when incubated in trypsin again lost their ability to induce immunity and killed all the mice.
Ribonuclease and hyaluronidase (Table I V) Incubation in ribonuclease (RNAse) for 60 minutes produced a fall in the electrophoretic mobility of the tumour cells. On inoculation into mice, however, such cells produced death from malignant ascites in the same manner as untreated cells. Hyaluronidase treatment for 60 minutes produced no change in electro- (1967) have studied the linkages of sialic acid on the surface of the Ehrlich ascites tumour and concluded that it mainly occupied the terminal positions on the oligosaccharide prosthetic groups of cell surface glycoproteins. Hydrolysis of these prosthetic groups revealed that the sialic acid was predominantly associated with N-acetyl D-galactosamine and that the molar ratio of these sugars approached unity. They therefore inferred that the prosthetic groups were disaccharides with sialic acid occupying the terminal nonreducing position (i.e. as N-acetyl neuraminosyl 2-? N-acetyl D galactosaminoyl-). They also detected the presence of N-glycolyl neuraminic acid on the same cells but indicated that its concentration was much less than sialic (N-acetyl neuraminic) acid. They also showed that the sialic acid content was associated with trypsin-labile proteins and not with cell wall lipids, thus confirming the observations of Gray (1963) who found only minute quantities of glycolipid in similar tumour cells. The action of neuraminidase is to catalyse the hydrolytic cleavage of 0-glycoside bonds between the potential keto-groups of N-acylated neuraminic acids and adjacent sugar residues (Gottschalk, 1960 (FLU N) failed to modify the immunogenicity of the tumour cells even after incubation for long periods. An explanation for these important differences may be found by examining the site of action of neuraminidase on the substrate. Sialic acid may be linked to sugar residues by several types of 0-glycoside bond. In most biological systems studied so far the commonest types of neuraminidase-sensitive bond are between the number 2 carbon atom of sialic acid and either the 3 or the 6 carbon atom of the adjacent aminosugar (Gottschalk, 1960) . VCN is known to cleave both the 2-3 and the 2-6 bonds readily (Drzeniek, 1967) , whereas myxovirus neuraminidases, including FLU N, only cleave 0-glycoside bonds of the 2-3 type. Burton (1963) has examined the time course of hydrolysis of both 2-3 and 2-6 bonds by OPN and revealed dramatic differences. Incubation with CPN for 30 minutes in his system resulted in release of approximately 90 per cent of 2-3 bound sialic acid but only minute amounts of that linked by the 2-6 bond. However after 3 hours incubation the percentage of 2-6 bound sialic acid released rose to 95-100 per cent. Thus incubation of the Landschiitz tumour cells in CPN for 30 minutes may only remove 2-3 bound sialic acid. Only after 3 hours' incubation is the 2-6 bond hydrolysed and the tumour cells rendered immunogenic. After CPN treatment of the cells for only 30 minutes however the cells were still susceptible to the unmasking effects of VCN, implying that the substrate sites were not blocked by inactive (or slow acting) CPN molecules. Hydrolytic cleavage of the disaccharide prosthetic group N-acetyl neuraminosyl 2-3 N-acetyl D galactosaminoyl alone, as would occur with FLU N, or CPN incubated for 30 minutes, is therefore insufficient to modify the immunogenicity of the tumour cells. Cleavage of N-acetyl neuraminosyl 2-6 N acetyl D galatosaminoyl-as well as the 2-3 prosthetic group must take place before the cells are capable of immunizing the recipient mice. It is not yet clear whether release of the 2-6 bound sialic acid alone is sufficient to unmask antigenic sites. Consequently it is not yet possible to explain the role played by the different types of 0-glycoside bond in the immunogenicity of these tumour cells. A quantitative steric difference in the three dimensional positions of 2-3 and 2-6 bound sialic acid may account for this phenomenon. However, it is not inconceivable that a quantitative effect of the total concentration of sialic acid in the cell periphery, regardless of the type of bond, may be operating in the present system. Gottschalk and Fazekas de St Groth (1960) have studied tryptic hydrolysis of a submaxillary sialomucin. The number of potential trypsin-sensitive sites cleaved was determined by assay of amide residues. They revealed that the number of sites hydrolysed by trypsin was greatly increased after prior neuraminidase treatment of the sialomucin. They therefore postulated that sialic acid inhibits tryptic hydrolysis by steric hindrance, i.e. the prosthetic group terminal sialic acid blocked underlying substrate sensitive sites from contact with the active centre of the trypsin molecule. It is of interest that the prosthetic groups they described were identical to those found by Langley and Ambrose (1967) on ascitic tumour cells. Furthermore the 0-glycoside bond between the saccharides in this prosthetic group was of the 2-6 type. In the present experiments the amount of mucinous material released from tumour cells by trypsin was grossly increased by pre-treatment of the cells with VCN. This finding suggests that the labile sites on cell wall mucins were protected in a similar manner by neuraminidase sensitive sialic acid, i.e. steric hindrance.
The immunogenicity of VCN-treated Landschutz cells was abolished by trypsin treatment but pretreatment of the cells with trypsin did not abolish the effects of a subsequent VCN treatment, implying that the sensitive antigenic determinant sites were protected from the action of trypsin by sialic acid. Trypsin treatment, followed by VCN and then retrypsinization resulted in "non-immunogenic " cells and subsequent death of the recipient mice. Trypsinized VCN-pretreated cells could not, moreover, be rendered immunogenic by subsequent VCN treatments. This suggests that the preliminary VCN treatment exposed all available antigenic sites to the disruptive effects of trypsin. These results may be interpreted, in the light of Gottschalk and Fazekas de St. Groths' (1960) work on sialomucins, as implying that steric factors are involved in inhibiting access of the active centre of trypsin to sensitive sites in the antigenic areas. However Neurath and Schwert (1950) have pointed out that tryptic hydrolysis may be inhibited by the electrostatic effects of ionized carboxyl groups in the region of the sensitive site. The powerfully ionogenic carboxyl group of the terminal sialic acid could possibly provide such electrostatic effects. At the moment it is not possible to dissociate steric hindrance from the local effects of charged groups. The molecular basis of enzyme-substrate interactions is similar in many ways to the relationship between an antigen and its complementary receptor site. It seems feasible that mechanisms hindering the enzymatic degradation of a given antigenic site would also inhibit immunological interactions involved in the detection of antigens with the same antigenic determinant groups.
The nature of the antigen(s) exposed by the action of neuraminidase on the Landschiitz tumour has not yet been explored. This tumour is a non-specific transplantable neoplasm which probably represents a malignant allograft. Therefore its antigenicity may well be related to the mouse histocompatibility antigen system. Nathensen and Davies (1966) have studied the chemical structure of solubilized H2 mouse isoantigens and believe them to be glycoproteins.
The nature of the specific determinant groups on these glycoproteins is not yet clear but the hexosamine content of the prosthetic groups may be involved in such specificity. These preparations do contain sialic acid but neuraminidase treatment does not affect their antigenic activity (Davies, 1967) . Thus the neuraminidase-sensitive sialic acids in these histocompatibility antigen preparations are probably not directly involved in the antigenic determinant site, although their underlying hexosamines may play a part. Therefore the elucidation of the structure of cell wall glycoproteins may have important implications for understanding the nature of antigenic determination and investigation of the role of sialic acid in thise glycoproteins may give some clues as to how the the expression of such antigenicity is moderated.
Neuraminidase treatment will expose antigens on the red cell. Saber, Drzeniek and Krupe (1965) have shown that carbohydrate groups demonstrating ABH blood-group specificity may be unmasked by treatment of several species of erythrocytes with neuraminidase. Similarly, treatment of erythrocytes will expose Forssmann antigen activity under conditions where untreated cells show no such activity (Drzeniek et al., 1966) . Burnet and Anderson (1947) have also shown that treatment of red cells with R.D.E. (receptor destroying enzyme neuraminidase) will bring about T-agglutination in many normal mammalian sera. They postulated that the enzyme had exposed a previously undetectable surface antigen on the red cells. It could be postulated that the effects of VCN on the Landschutz ascites tumour are also due to a form of T-agglutination.
Our previous studies indicate that this is not so. The growth of VCN-treated cells in irradiated (Bagshawe and Currie, 1968) or hydrocortisonized mice (Currie and Bagshawe, 1968) and the lack of high titre agglutination of normal mouse sera for VCN-treated cells would indicate that factors other than T-agglutination must be involved.
Although the present studies have been confined mainly to sialic acid it is not inconceivable that other cell surface components may modify the expression of antigenicity by cells. Weiss (1968) has indicated that RNA may be an integral part of the cell periphery in several cell types. The effects of RNAse on the electrophoretic mobility of the Landschutz tumour suggest that RNA may well be present on the cell surface. However RNAse had no effect on the immunogenicity of this tumour. Hyaluronidase had no effect on either its electrophoretic mobility or its immunogenicity indicating the probable absence of hyaluronic acid from the glycocalyx of this particular tumour. However the chemical structure of the cell surface is undoubtedly very complex and further work is needed to evaluate the role of various other cell surface components in modifying the immunogenic properties of cells.
The relationship between the cell surface glycoproteins in the glycocalyx and such surface phenomena as contact inhibition, intercellular adhesiveness and antigenicity is not yet clear. Extensive studies of the action of neuraminidase on glycoprotein prosthetic groups on the cell surface may provide valuable inform-ation about the molecular structures responsible for moderating such cellular interactions and may give some insight into the " chemistry of antigenicity ".
SUMMARY
Experiments were performed to elucidate the role of sialic acid and its mode of linkage to the cell surface in inhibiting the detection of antigens on the Landschuitz ascites tumour by the host's immunological mechanisms. The immunogenicity of this tumour was greatly enhanced after in vitro incubation in neuraminidase. The antigenic sites exposed by neuraminidase were destroyed by trypsin. However, prior treatment with trypsin did not affect the subsequent exposure of antigen(s) by neuraminidase. Various sequential enzyme treatments of the tumour cells with trypsin and/or neuraminidase suggest that the trypsinsensitive components of the antigenic determinant groups are protected from the active centre of the trypsin molecule by neuraminidase-susceptible sialic acids. It is proposed that these antigenic sites may be protected from the host's immunocompetent cells in a similar manner.
Neuraminidases derived from different species of micro-organism display different effects on the immunogenicity of this tumour. Vibrio cholerae neuraminidase readily unmasked the antigenic sites on the tumour cells. The enzyme which comprises part of the influenza virion had no effect, whereas Clostridium perfringens neuraminidase only produced an effect after prolonged incubation. These enzymes have different substrate specificities and it is suggested that the enzymatic removal of cell wall sialic acid bound to hexosamines by a 2-3 0-glycosidic linkage is insufficient to unmask antigernic sites. Hydrolysis of the 2-6 bonds appears to be essential.
Ribonuclease and hyaluronidase treatment in vitro had no effect on the subsequent in vivo development of tumour cells. It was incidentally revealed that ribonucleic acid is probably present in the cell periphery of the Landschuitz tumour cells.
It is suggested that the neuraminidase-sensitive terminal sialic acid moiety of cell surface glycoprotein prosthetic groups inhibits access to underlying antigenic determinant areas; this phenomenon probably depending on the type of 0-glycoside bond between the sialic acid and underlying hexosamines. Although it is not yet possible to rule out the local inhibitory electrostatic effects of the carboxyl groups of sialic acid it seems probable that the blocking effects of this sialic acid are due to steric hindrance. 
